BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7534105)

  • 21. A developmental context for multiple genetic alterations in Wilms' tumor.
    Feinberg AP
    J Cell Sci Suppl; 1994; 18():7-12. PubMed ID: 7883796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells.
    Reeve AE; Sih SA; Raizis AM; Feinberg AP
    Mol Cell Biol; 1989 Apr; 9(4):1799-803. PubMed ID: 2542777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis.
    Austruy E; Candon S; Henry I; Gyapay G; Tournade MF; Mannens M; Callen D; Junien C; Jeanpierre C
    Genes Chromosomes Cancer; 1995 Dec; 14(4):285-94. PubMed ID: 8605117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
    Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
    Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple genetic abnormalities of 11p15 in Wilms' tumor.
    Feinberg AP
    Med Pediatr Oncol; 1996 Nov; 27(5):484-9. PubMed ID: 8827078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver.
    Byrne JA; Simms LA; Little MH; Algar EM; Smith PJ
    Genes Chromosomes Cancer; 1993 Oct; 8(2):104-11. PubMed ID: 7504513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].
    Tsuchida Y; Yokomori K; Choi SH
    Nihon Rinsho; 1995 Nov; 53(11):2742-8. PubMed ID: 8538037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unbalanced translocation of chromosome 3p in Wilms' tumor.
    Walton JM; Lee CL; Mikhail E; Welch JP; Gillis DA
    J Pediatr Surg; 1992 Oct; 27(10):1311-4. PubMed ID: 1328583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS).
    Bliek J; Gicquel C; Maas S; Gaston V; Le Bouc Y; Mannens M
    J Pediatr; 2004 Dec; 145(6):796-9. PubMed ID: 15580204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
    Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
    Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
    Grundy PE; Telzerow PE; Breslow N; Moksness J; Huff V; Paterson MC
    Cancer Res; 1994 May; 54(9):2331-3. PubMed ID: 8162576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11.
    Radice P; Perotti D; De Benedetti V; Mondini P; Radice MT; Pilotti S; Luksch R; Fossati Bellani F; Pierotti MA
    Genomics; 1995 Jun; 27(3):497-501. PubMed ID: 7558032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The M1 subunit of ribonucleotide reductase refines mapping of genetic rearrangements at chromosome 11p15.
    Byrne JA; Little MH; Smith PJ
    Cancer Genet Cytogenet; 1992 Apr; 59(2):206-9. PubMed ID: 1316226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of genomic imprinting in Wilms' tumour and overgrowth disorders.
    Reeve AE
    Med Pediatr Oncol; 1996 Nov; 27(5):470-5. PubMed ID: 8827076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chromosome 11 region flanking the t(11;14) breakpoint in human T-ALL is deleted in Wilms' tumor hybrids.
    Finver SN; Martiniere C; Kagan J; Cavenee W; Croce CM
    Oncogene Res; 1989; 5(2):143-8. PubMed ID: 2558334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases.
    Safford SD; Goyeau D; Freemerman AJ; Bentley R; Everett ML; Grundy PE; Skinner MA
    Ann Surg Oncol; 2003 Mar; 10(2):136-43. PubMed ID: 12620908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beck-Wiedemann syndrome and Wilms' tumour.
    Ward A
    Mol Hum Reprod; 1997 Feb; 3(2):157-68. PubMed ID: 9239720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
    Cowell JK; Groves N; Baird P
    Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paternal origin of 11p15 duplications in the Beckwith-Wiedemann syndrome. A new case and review of the literature.
    Brown KW; Gardner A; Williams JC; Mott MG; McDermott A; Maitland NJ
    Cancer Genet Cytogenet; 1992 Jan; 58(1):66-70. PubMed ID: 1728953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biology of Wilms' tumour.
    Pritchard-Jones K; Hawkins MM
    Lancet; 1997 Mar; 349(9053):663-4. PubMed ID: 9078193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.